Suvoda and Greenphire Merge; Thoma Bravo Leads Investment
April 24, 2025
Suvoda and Greenphire have completed a merger to form a unified clinical-trial technology company operating under the Suvoda name. Thoma Bravo is the lead strategic investor in the combined business, with Bain Capital Tech Opportunities and LLR Partners taking significant minority stakes to support the expanded end-to-end platform for sponsors, sites, and patients.
- Buyers
- Thoma Bravo, Bain Capital Tech Opportunities Fund, LLR Partners
- Targets
- Suvoda, Greenphire
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Thoma Bravo Acquires Greenphire from The Riverside Company
May 26, 2021
Cloud & SaaS
Thoma Bravo has agreed to acquire Greenphire, a King of Prussia, Pennsylvania–based leader in financial lifecycle management software for clinical trials, from The Riverside Company in a strategic growth investment. The deal (expected to close in Q2 2021) will support Greenphire’s product innovation and global expansion; financial terms were not disclosed.
-
Greenphire Acquires Clincierge to Expand Clinical Trial Participant Support
February 1, 2024
Healthcare Services
Greenphire, a Thoma Bravo-backed provider of clinical trial software, has acquired Clincierge, a concierge travel and logistics service for clinical trial participants. The acquisition expands Greenphire's participant support capabilities by integrating high-touch travel and logistics services with its payment and trial-support technology to improve participant experience and trial efficiency.
-
Quorum Software (Thoma Bravo) Merges with Aucerna and Acquires TietoEVRY’s Oil & Gas Software Business
February 15, 2021
Energy
Thoma Bravo‑backed Quorum Software will merge with Aucerna and the newly combined company has acquired TietoEVRY’s Oil & Gas software business (including Energy Components and DaWinci). The transactions create a consolidated, cloud‑first global leader in energy software, expanding Quorum’s product portfolio and global footprint across upstream, midstream and downstream markets.
-
Thoma Bravo Acquires Coupa Software
February 28, 2023
Cloud & SaaS
Thoma Bravo completed an all-cash acquisition of Coupa Software valued at approximately $8.0 billion, with a significant minority investment from a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA). Coupa stockholders received $81.00 per share, Coupa will be delisted from Nasdaq, and Thoma Bravo said it will invest to accelerate product innovation and growth, including potential M&A.
-
Thoma Bravo and 7RIDGE Invest in Trading Technologies
November 10, 2025
Cloud & SaaS
Thoma Bravo has closed an investment in Trading Technologies, joining existing investor 7RIDGE in the company's ownership to support the next phase of platform expansion and product innovation. Terms were not disclosed; advisors to the transaction included Houlihan Lokey and Barclays for Trading Technologies and Ardea Partners and Goodwin Procter for Thoma Bravo.
-
Thoma Bravo Invests in Bluesight to Support Bluesight's Acquisition of Medacist
July 17, 2023
Healthcare Services
Thoma Bravo made a strategic growth investment in Bluesight to support Bluesight's acquisition of Medacist, combining two medication-management and drug-diversion analytics businesses into a single hospital pharmacy software platform. The combined company will expand Bluesight's medication intelligence capabilities and serve more than 2,000 hospitals across North America; committed financing was led by Monroe Capital and existing investor New Leaf Ventures remains invested. Financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.